Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.
Press releases published on September 21, 2025
Major Developments Announces Patrice Evra as Project Partner for Colibri Views at Landmark RAK Central Event
Patrice Evra joins Major Developments for Colibri Views, unveiling the UAE's first rooftop Footbot and boosting RAK Central’s Live-Work-Play vision. RAS AL KHAIMAH, UNITED ARAB EMIRATES, September 21, 2025 /EINPresswire.com/ -- Major Developments made …
Burjdeal Joins FasterCapital Equitypilot Program to Accelerate UAE Classifieds Growth
DUBAI, DUBAI, UNITED ARAB EMIRATES, September 21, 2025 /EINPresswire.com/ -- BurjDeal, an innovative UAE-based classified platform, today announced a strategic partnership with global startup accelerator FasterCapital through its Equitypilot program. …
GeeM Home Becomes Dubai's Leading Full-Service Home Maintenance Provider
Trusted home maintenance company introduces enhanced AC, plumbing, electrical services with 24/7 emergency response for residential properties. DUBAI, DUBAI, UNITED ARAB EMIRATES, September 21, 2025 /EINPresswire.com/ -- GeeM Home, a premier home …
Ethereum-Based DeFi Crypto Mutuum Finance (MUTM) Raises Over $16 Million With More Than 720M Tokens Sold
DUBAI, United Arab Emirates, Sept. 21, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), an Ethereum-based decentralized finance (DeFi) protocol, has raised over $16 million today. This traction is fueled by investor inflows supporting Mutuum Finance in its …
Mutuum Finance (MUTM) Raises $16 Million While Advancing Toward Platform Release
DUBAI, United Arab Emirates, Sept. 21, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a project currently in its presale phase, has reached the milestone of raising more than $16 million. This progress moves the initiative closer to its token debut while …
Patients Taking AUSTEDO XR® (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR® (deutetrabenazine) extended-release tablets Patients reported high satisfaction (>89%) with AUSTEDO XR, with 96% …
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with olanzapine LAI (TEV-'749) and its long-term systemic safety profile was consistent with other olanzapine …